Creative Medical Technology Holdings (CELZ) Debt Ratio (2010 - 2023)
Creative Medical Technology Holdings (CELZ) posted quarterly Debt Ratio of 0.0 for Q1 2023, down 36.08% year-over-year from 0.0 in Q1 2022, and up 25.98% quarter-over-quarter from 0.0 in Q4 2022.
Creative Medical Technology Holdings (CELZ) Debt Ratio (2010 - 2023) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Debt Ratio for 14 consecutive years, with 0.0 the latest figure, recorded in Q1 2023.
- In Q1 2023, Debt Ratio fell 36.08% year-over-year to 0.0; the TTM figure through Mar 2023 stood at 0.0 (down 36.08% YoY), while the FY2022 annual figure was 0.0, down 41.27% from the prior year.
- Debt Ratio rose to 0.0 in Q1 2023 per CELZ's latest filing, from 0.0 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.32 in Q2 2021 and bottomed at 0.0 in Q2 2022.
- Historically, Debt Ratio has averaged 0.03 across 5 years, with a median of 0.02 in 2019.
- Annual changes were most pronounced in 2021 — Debt Ratio soared 1228.95% — and 2022, when it plunged 99.81%.
- Creative Medical Technology Holdings' Debt Ratio stood at 0.02 in 2019, then declined by 26.05% to 0.02 in 2020, then slumped by 91.63% to 0.0 in 2021, then tumbled by 41.27% to 0.0 in 2022, then rose by 25.98% to 0.0 in 2023.
- Business Quant data shows CELZ's Debt Ratio at 0.0 in Q1 2023, 0.0 in Q4 2022, and 0.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.26 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.47 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.03 |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.32 |
| Mar 31, 2021 | 0.04 |
| Dec 31, 2020 | 0.02 |
| Sep 30, 2020 | 0.03 |
| Jun 30, 2020 | 0.02 |
| Mar 31, 2020 | 0.02 |
| Dec 31, 2019 | 0.02 |
| Sep 30, 2019 | 0.03 |
| Jun 30, 2019 | 0.03 |
| Mar 31, 2019 | 0.02 |
| Dec 31, 2018 | 0.02 |
| Sep 30, 2018 | 0.03 |
| Jun 30, 2018 | 0.04 |